Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Moodys
Chubb
Deloitte
Cipla
McKinsey
McKesson
Baxter
Harvard Business School

Generated: August 14, 2018

DrugPatentWatch Database Preview

AMIODARONE HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Amiodarone Hydrochloride, and what generic alternatives are available?

Amiodarone Hydrochloride is a drug marketed by Akorn, Aurobindo Pharma Ltd, Bedford, Bedford Labs, Ben Venue, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Hospira Inc, Intl Medication Sys, Mylan Institutional, Par Sterile Products, Teva Pharms Usa, Wockhardt, Apotex Inc, Mayne Pharma Inc, Murty Pharms, Mylan, Sandoz, Taro Pharm, Teva, Teva Pharms, and Zydus Pharms Usa Inc. and is included in twenty-nine NDAs.

The generic ingredient in AMIODARONE HYDROCHLORIDE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.

Drug patent expirations by year for AMIODARONE HYDROCHLORIDE
Synonyms for AMIODARONE HYDROCHLORIDE
(2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone hydrochloride
(2-butyl-1-benzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]methanone;hydrochloride
(2-Butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone hydrochloride (1:1)
(2-butylbenzofuran-3-yl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]methanone hydrochloride
(2-Butylbenzofuran-3-yl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)methanone hydrochloride
{2-[4-(2-butyl-1-benzofuran-3-carbonyl)-2,6-diiodophenoxy]ethyl}diethylamine hydrochloride
19774-82-4
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone hydrochloride
2-Butyl-3-benzofuranyl 4-[(2-diethylamino)ethoxy] 3,5-diiodophenyl ketone, hydrochloride
2-Butyl-3-benzofuranyl)-[4-[2-(diethylamino)ethoxy]-3,5-diiodo-phenyl]-methanone hydrochloride
2-Butyl-3-benzofuryl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone hydrochloride
51087 N HCl
774A824
976728SY6Z
A 8423
AB0012080
AC-078
AC1L9AZ7
ACT02681
AK149490
AKOS015844018
Ambap19774-82-4
Amio-Aqueous
Amiodar
Amiodarone (hydrochloride)
Amiodarone HCL
Amiodarone hydrochloride (JP17/USAN)
Amiodarone hydrochloride [JAN]
Amiodarone hydrochloride [USP:JAN]
Amiodarone Hydrochloride 1.0 mg/ml in Methanol (as free base)
Amiodaronum hydrochloride
AN-6656
Ancaron
Ancaron (TN)
Angoron
API0001454
Atlansil
BBC/822
BC207085
BG0032
C25H30ClI2NO3
calcium channel (L type) blocker
CAS-19774-82-4
CC-24084
CCG-39607
CHEBI:2664
CHEMBL1083993
Cordarex
Cordarone (TN)
CPD000058296
CS-1371
D00636
DSSTox_CID_17185
DSSTox_GSID_37185
DSSTox_RID_79304
DTXSID7037185
EINECS 243-293-2
EU-0100122
FT-0083531
FT-0622300
HE072922
HMS1569A20
HSDB 6525
HY-14188
Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl, hydrochloride
Ketone,5-diiodophenyl, hydrochloride
KS-5249
L 3428 labaz
LP00122
Methanone, (2-butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl)-, hydrochloride (9CI)
Methanone,5-diiodophenyl]-, hydrochloride
MFCD00069204
Miodrone
MLS000028520
MLS001076313
MLS001424272
MLS002222247
MolPort-002-915-715
NC00423
NCGC00015096-12
NCGC00093613-01
NCGC00093613-02
NCGC00093613-03
NCGC00093613-04
NCGC00254295-01
NCGC00260807-01
Nexterone
NSC 85442
NSC-759560
NSC-85442
NSC759560
NSC85442
Opera_ID_568
Pacerone
Pharmakon1600-02300165
PM-101
Prestwick_707
Q-200626
Renodoron
Ritmocardyl
Rythmarone
s1979
SAM001246646
SCHEMBL41348
SK&F-33134-A
SKF 33134 A
SKF 33134-A
SMR000058296
SPECTRUM2300165
TL8001651
Tox21_113478
Tox21_300395
Tox21_500122
Trangorex
UNII-976728SY6Z
W-5062
WLN: T56 BOJ C4 DVR CI EI DO2N2&2 &GH
Z2210825534
ZX-AS005021

US Patents and Regulatory Information for AMIODARONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro Pharm AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 076362-002 Dec 2, 2003 RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 075315-001 Dec 23, 1998 AB RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Taro Pharm AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 076362-001 Nov 29, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 075315-002 Jun 30, 2000 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 076232-001 Jul 5, 2006 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 077834-001 Oct 30, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Argus Health
Cerilliant
Teva
US Army
Colorcon
UBS
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.